117 related articles for article (PubMed ID: 10789960)
21. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.
Sato T; Kobayashi R; Yasuda K; Kaneda M; Iguchi A; Kobayashi K
Pediatr Blood Cancer; 2008 Dec; 51(6):774-7. PubMed ID: 18661495
[TBL] [Abstract][Full Text] [Related]
22. Continuous infusion of ceftazidime in the empiric treatment of febrile neutropenic children with cancer.
Dalle JH; Gnansounou M; Husson MO; Lambilliotte A; Mazingue F; Nelken B
J Pediatr Hematol Oncol; 2002 Dec; 24(9):714-6. PubMed ID: 12468910
[TBL] [Abstract][Full Text] [Related]
23. Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study.
Erman M; Akova M; Akan H; Korten V; Ferhanoğlu B; Köksal I; Cetinkaya Y; Uzun O; Unal S;
Scand J Infect Dis; 2001; 33(11):827-31. PubMed ID: 11760163
[TBL] [Abstract][Full Text] [Related]
24. Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
Egerer G; Goldschmidt H; Streich N; Ehrhard I; Sonntag HG; Haas R
Support Care Cancer; 1999 Sep; 7(5):336-42. PubMed ID: 10483819
[TBL] [Abstract][Full Text] [Related]
25. Comparison of meropenem with ceftazidime as monotherapy of cancer patients with chemotherapy induced febrile neutropenia.
Malik I; Shaharyar
J Pak Med Assoc; 2002 Jan; 52(1):15-8. PubMed ID: 11963577
[TBL] [Abstract][Full Text] [Related]
26. Three-step empiric treatment for severely neutropenic patients with fever: ceftazidime--vancomycin--amphotericin B.
Koeppler H; Pflueger KH; Seitz R; Havemann K
Infection; 1989; 17(3):142-5. PubMed ID: 2661438
[TBL] [Abstract][Full Text] [Related]
27. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen.
J Antimicrob Chemother; 1995 Jul; 36(1):185-200. PubMed ID: 8537265
[TBL] [Abstract][Full Text] [Related]
28. Empiric monotherapy for febrile neutropenia--a randomized study comparing meropenem with ceftazidime.
Lindblad R; Rödjer S; Adriansson M; Andreasson B; Bäckström B; Johansson P; Karlsson K; Rhedin C; Turesson I
Scand J Infect Dis; 1998; 30(3):237-43. PubMed ID: 9790130
[TBL] [Abstract][Full Text] [Related]
29. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
Freifeld AG; Walsh T; Marshall D; Gress J; Steinberg SM; Hathorn J; Rubin M; Jarosinski P; Gill V; Young RC
J Clin Oncol; 1995 Jan; 13(1):165-76. PubMed ID: 7799016
[TBL] [Abstract][Full Text] [Related]
30. Penicillin or vancomycin plus ceftazidime in febrile neutropenic patients after stem cell transplantation.
Kargar Samani K; Vandercam B; Straetmans N; Michaux L; Ferrant A
Acta Clin Belg; 2000; 55(5):279-84. PubMed ID: 11109643
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients.
Escalante CP; Weiser MA; Manzullo E; Benjamin R; Rivera E; Lam T; Ho V; Valdres R; Lee EL; Badrina N; Fernandez S; DeJesus Y; Rolston K
Support Care Cancer; 2004 Sep; 12(9):657-62. PubMed ID: 15185134
[TBL] [Abstract][Full Text] [Related]
32. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
33. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
[TBL] [Abstract][Full Text] [Related]
34. Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.
de la Cámara R; Figuera A; Sureda A; Hermida G; Verge G; Olalla I; Fernández Rañada JM; Domingo Albos A
Haematologica; 1997; 82(6):668-75. PubMed ID: 9580087
[TBL] [Abstract][Full Text] [Related]
35. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
[TBL] [Abstract][Full Text] [Related]
36. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.
Hung KC; Chiu HH; Tseng YC; Wang JH; Lin HC; Tsai FJ; Peng CT
J Microbiol Immunol Infect; 2003 Dec; 36(4):254-9. PubMed ID: 14723254
[TBL] [Abstract][Full Text] [Related]
37. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients.
Wang FD; Liu CY; Hsu HC; Gau JP; Chau WK; Haung ML; Ho CH
Chemotherapy; 1999; 45(5):370-9. PubMed ID: 10473925
[TBL] [Abstract][Full Text] [Related]
40. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
